13F Data
13F filer · CIK 1616824

BML Capital Management, LLC

ZIONSVILLE, IN · filing since Q4 2022 · last filing Nov 6, 2026
Reported value
$187.6M
+$11.6M vs prior
Positions
20
New / sold out
3 / 1
Added / reduced
4 / 4
Turnover
4.3%
buys $13.3M · sells $7.8M
Top-10 weight
89.0%

Biggest buys vs Q2 2026

ChangeSecurityShares changeChange %Est. trade value
NewSEER INC+2,186,587–+$4.9M
AddedCONNECT BIOPHARMA HLDGS LTD+3,291,113+574.1%+$3.6M
AddedPMV PHARMACEUTICALS INC+2,000,000+37.5%+$3.3M
NewLENZ THERAPEUTICS INC+283,114–+$1.1M
AddedKRAFT HEINZ CO+10,000+2.2%+$227.2K
NewKARYOPHARM THERAPEUTICS INC+71,839–+$87.6K
AddedORAMED PHARMACEUTICALS INC+18,123+2.1%+$84.6K

Biggest sells vs Q2 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedACLARIS THERAPEUTICS INC-1,020,000-8.5%$-5.4M
ReducedTESLA INCPUT-225-60.0%$-1.0M
ReducedATEA PHARMACEUTICALS INC-198,672-2.9%$-1.0M
Sold outCORE SCIENTIFIC INC NEWPUT-800-100.0%$-298.0K
ReducedJANUX THERAPEUTICS INC-3,835-2.5%$-66.3K

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2022: $104.7MQ1 2023: $115.7MQ2 2023: $111.2MQ3 2023: $108.9MQ4 2023: $129.1MQ1 2024: $151.7MQ2 2024: $140.1MQ3 2024: $169.9MQ4 2024: $161.0MQ1 2025: $123.6MQ2 2025: $132.2MQ3 2025: $109.2MQ4 2025: $113.7MQ1 2026: $155.8MQ2 2026: $176.1MQ3 2026: $187.6M
Q4 2022Q3 2026

Holdings · Q3 2026

#SecuritySharesValueWeight
1ACLARIS THERAPEUTICS INCCOM10,955,000$57.6M30.71%
2ATEA PHARMACEUTICALS INCCOM6,753,658$35.2M18.75%
3ENGENE THERAPEUTICS INCCOM6,669,908$13.3M7.11%
4PMV PHARMACEUTICALS INCCOM7,330,000$12.2M6.52%
5KRAFT HEINZ COCOM475,000$10.8M5.75%
6TILLYS INCCL A2,150,000$10.0M5.31%
7CARMAX INCCOM172,500$9.5M5.07%
8OUTSET MED INCCOM NEW2,519,701$7.6M4.03%
9TARGET CORPCOM37,500$5.9M3.13%
10SEER INCCOM CL A2,186,587$4.9M2.60%
10 more rows. Subscribe for $29/month to see every row, download the data and use the API.